Skye Bioscience, Inc. Common Stock (SKYE)

NASDAQ HEALTHCARE
$0.93 -12.25% RSI 58 Neutral Add Alert

Moving Averages

SMA 200
$2.21
Price below

Company Profile

Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes therapeutic drugs that modulate the endocannabinoid system. The company is headquartered in San Diego, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$25.61M
P/E Ratio
None
EPS
$-1.3
Beta
2.863
Dividend Yield
0.00%
52-Week High
$5.75
52-Week Low
$0.61

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 57.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 50.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 50.0
MRNA
Moderna Inc
RSI 36.0
VKTX
Viking Therapeutics Inc
RSI 38.0

Data last updated: March 12, 2026 at 2:14 AM EDT

Track SKYE for free

Get e-mail RSI alerts when Skye Bioscience, Inc. Common Stock enters oversold or overbought territory. Free forever.

Add Alert